Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionTCI Wealth Advisors, Inc.
Latest Disclosed Ownership4,569 shares
Latest Disclosed Value $ 277,095
TCI Wealth Advisors, Inc. ownership in BRM / Bristol-Myers Squibb Company

On April 27, 2026 - TCI Wealth Advisors, Inc. filed a 13F-HR form disclosing ownership of 4,569 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $239,507 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 4,769 shares of Bristol-Myers Squibb Company. This represents a change in shares of -4.19% during the quarter. The current value of the position is $216,708 USD.

TCI Wealth Advisors, Inc. has a history of taking positions in derivatives of the underlying security (BRM) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:BRM / Bristol-Myers Squibb Company Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,569 -200 -4.19 277 7.78 0.0147
2026-02-02 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,769 44 0.93 257 20.66 0.0142
2025-10-14 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 4,725 -618 -11.57 213 -13.77 0.0127
2025-07-16 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 5,343 -597 -10.05 247 -31.77 0.0169
2025-04-21 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 5,940 374 6.72 362 15.29 0.0290
2025-01-23 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 5,566 122 2.24 315 11.74 0.0263
2024-10-24 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 5,444 -1,282 -19.06 282 0.72 0.0237
2024-07-30 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 6,726 -156 -2.27 279 -25.20 0.0264
2024-05-07 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 6,882 402 6.20 373 12.35 0.0368
2024-02-06 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 6,480 -143 -2.16 333 -13.54 0.0355
2023-10-31 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 6,623 -267 -3.88 384 -12.73 0.0491
2023-08-04 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 6,890 -920 -11.78 441 -18.67 0.0563
2023-05-03 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 7,810 -190 -2.38 541 -5.91 0.0702
2023-02-07 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 8,000 711 9.75 576 11.00 0.0797
2022-11-08 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 7,289 584 8.71 518 0.39 0.0838
2022-07-19 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 6,705 177 2.71 516 8.18 0.0790
2022-04-29 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 6,528 117 1.82 477 19.25 0.0715
2022-01-24 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 6,411 -698 -9.82 400 -4.99 0.0591
2021-10-29 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 7,109 -1,497 -17.39 421 -26.78 0.0642
2021-08-02 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 8,606 85 1.00 575 6.88 0.0972
2021-04-29 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 8,521 302 3.67 538 5.49 0.2282
2021-01-21 2020-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 8,219 -12,417 -60.17 510 -59.00 0.2279
2020-10-20 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 20,636 1 0.00 1,244 2.56 0.4916
2020-07-20 2020-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 20,635 12 0.06 1,213 5.48 0.5186
2020-04-14 2020-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 20,623 -1,705 -7.64 1,150 -19.75 0.5673
2020-01-27 2019-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 22,328 1,256 5.96 1,433 34.05 0.5566
2019-10-17 2019-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 21,072 0 0.00 1,069 11.82 0.4748
2019-07-23 2019-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 21,072 -6,156 -22.61 956 -26.40 0.4306
2019-04-11 2019-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 27,228 -23 -0.08 1,299 -8.33 0.5712
2019-01-17 2018-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 27,251 -3,083 -10.16 1,417 -24.75 0.6864
2018-11-02 2018-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 30,334 -56 -0.18 1,883 11.95 0.7872
2018-07-26 2018-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 30,390 -2,021 -6.24 1,682 -17.95 0.7478
2018-04-30 2018-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 32,411 -11 -0.03 2,050 3.17 0.9495
2018-02-01 2017-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 32,422 -3,720 -10.29 1,987 -13.76 0.8726
2017-10-24 2017-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 36,142 678 1.91 2,304 16.60 1.1275
2017-08-10 2017-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 35,464 -754 -2.08 1,976 0.30 1.0090
2017-05-04 2017-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 36,218 -244 -0.67 1,970 -7.56 1.0279
2017-02-10 2016-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 36,462 277 0.77 2,131 9.23 1.1174
2016-11-01 2016-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 36,185 -657 -1.78 1,951 -28.01 1.0608
2016-08-09 2016-06-30 13F Bristol-Myers Squibb COM 110122108 36,842 -35 -0.09 2,710 15.03 1.5038
2016-04-29 2016-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 36,877 -682 -1.82 2,356 -8.82 1.3058
2016-02-10 2015-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 37,559 -94 -0.25 2,584 15.93 1.4394
2015-11-02 2015-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 37,653 243 0.65 2,229 -10.45 1.3433
2015-08-10 2015-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 37,410 -596 -1.57 2,489 1.55 1.4249
2015-04-30 2015-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 38,006 -371 -0.97 2,451 8.21 1.5383
2015-02-06 2014-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 38,377 -368 -0.95 2,265 14.22 1.4014
2014-11-05 2014-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 38,745 315 0.82 1,983 6.38 1.2499
2014-08-11 2014-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 38,430 12 0.03 1,864 -6.61 1.1220
2014-05-15 2014-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 38,418 -1,000 -2.54 1,996 -4.73 1.3014
2014-01-21 2013-12-31 13F Bristol-Myers Squibb COM 110122108 39,418 0 0.00 2,095 14.86 1.3143
2013-10-25 2013-09-30 13F Bristol-Myers Squibb COM 110122108 39,418 100 0.25 1,824 3.81 1.3865
2013-09-12 2013-06-30 13F Bristol-Myers Squibb COM 110122108 39,318 31,100 378.44 1,757 419.82 1.3342
2013-10-18 2013-03-31 13F Bristol-Myers Squibb COM 110122108 8,218 1,000 13.85 338 43.83 0.3710
2013-10-18 2012-12-31 13F Bristol-Myers Squibb COM 110122108 7,218 7,218 235 0.2848
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-07-16 2025-06-30 13F BRISTOL-MYERS SQUIBB COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-04-21 2025-03-31 13F BRISTOL-MYERS SQUIBB COM Call 500 30 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.